

THE BRIEFING
“..WE ARE NOT POWERLESS, AND THROUGH OUR audios and VIDEOS, WRITINGS, AND PHOTOGRAPHS, WE WILL EXPOSE THE ABUSES AND TYRANNY …JUST AS THE VIDEO WAS RECORDED BY THE CELL PHONE CAMERA OF YOUNG Darnella Frazier, BORE WITNESS TO THE MURDER OF GEORGE FLOYD THE BLOG youarewithinthenorms.com bears WITNESS AND BOTH ALLOWS THE SYSTEM TO BE HELD ACCOUNTABLE..”
REPORTED BY youarewithinthenorms.com
NORMAN J. CLEMENT, RPH., DDS, NORMAN L. CLEMENT, PHARM-TECH, MALACHI F. MACKANDAL, PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO, ESQ., INC.T. SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT, BS., MS., MBA. HARVEY JENKINS, MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., IN THE SPIRIT OF WALTER F. WRENN III., MD., JULIE KILLINGWORTH, LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, IN THE SPIRIT OF WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., IN THE SPIRIT OF RICHARD KAUL, MD., IN THE SPIRIT OF LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS


FAILED SHARED DECISION MAKING AND THE FAILURE OF THE MONTANA BOARD OF MEDICINE
Case Presentation: The Clinical Scenario of Dakota White
Acute hospital admissions for patients with high-complexity chronic illness rarely occur in isolation. Physical health, outpatient access, systemic co-morbidities, and regulatory environments dictate how an acute metabolic or pain crisis unfolds. This case study examines the inpatient management of Dakota White, illustrating how sudden administrative and regulatory disruptions in outpatient pain care can precipitate severe, life-threatening metabolic crises in complex patients.

An extensive deep dive analysis on the mistreatment of Dakota White

| Clinical Parameter | Patient Detail |
| Demographics & History | • 33-year-old male (Dakota White) • Managed continuously under outpatient care by Dr. Mark Ibsen for 1.5 years prior to acute presentation |
| Primary Diagnoses | • Insulin-dependent diabetes mellitus • Complex Regional Pain Syndrome (CRPS) • Diabetic neuropathy • Gastroparesis |
| Baseline Outpatient Regimen | • Subcutaneous (SQ) hydromorphone: 15–20 mg SQ every 2–3 hours • Transitioned to SQ route because local retail pharmacies in Idaho refused to fill his high-dose chronic opioid prescriptions, creating severe access barriers |
| Acute Trigger Event | • Abrupt cessation of prescribed SQ hydromorphone on October 14 • Driven by the summary suspension of Dr. Ibsen’s medical license by the Montana Board of Medicine • Deprived of chronic opioid therapy, the patient suffered acute withdrawal, directly precipitating severe Diabetic Ketoacidosis (DKA) |
| Admission Location | • St. Luke’s Hospital ICU in Meridian, Idaho • Initial 10-day admission; discharged, then immediately readmitted to the ICU following an emergency outpatient clinic presentation |

Why This Case Matters (“So What?”)
For medical trainees and hospitalists, chronic pain management in patients with complex co-morbidities must be understood as a physiological stabilization necessity, not merely a subjective comfort measure. When legal or administrative actions abruptly disrupt a chronic, high-dose opioid regimen across state lines, the consequences extend far beyond heightened nociception.

In a patient with insulin-dependent diabetes, acute opioid withdrawal acts as a severe systemic stressor. The sudden withdrawal triggers an uncompensated stress response that directly disrupts metabolic homeostasis, leading to emergency Intensive Care Unit (ICU) admission for severe Diabetic Ketoacidosis (DKA). Patients caught in these regulatory disruptions become “pain refugees”—individuals whose stable outpatient regimens are severed by administrative intervention, leaving emergency departments and hospitalists to manage the resulting systemic collapse.

Clinical Pearl: The DKA-Opioid Withdrawal Cascade
The physiological mechanism linking sudden chronic pain treatment disruption to metabolic collapse follows a distinct cascade:
- Sudden Opioid Cessation: Abrupt withdrawal eliminates tonic central nervous system inhibition.
- Sympathetic Storm: Severe withdrawal triggers a massive release of endogenous catecholamines (epinephrine and norepinephrine) alongside cortisol and glucagon.
- Gastrointestinal & Fluid Loss: Intractable vomiting and diarrhea cause acute hypovolemia, dehydration, and electrolyte depletion.
- Acute Insulin Resistance: Elevated counter-regulatory hormones impair insulin receptor sensitivity and suppress baseline insulin efficacy, unmasking rapid lipolysis and ketogenesis.
- Metabolic Ketoacidosis: Unchecked hepatic ketone production drives profound metabolic acidosis (DKA), requiring immediate ICU-level resuscitation and continuous insulin administration.
Understanding the acute systemic crisis of severe DKA requires examining the specific underlying physiological and pharmacokinetic challenges encountered during inpatient management.

Physiological & Pharmacokinetic Breakdown of Inpatient Failure
During Dakota White’s initial 10-day hospitalization and subsequent ICU readmission at St. Luke’s Hospital, the inpatient medical team attempted to manage his pain and withdrawal using traditional oral and intravenous routes. These standard inpatient protocols failed due to clear physiological barriers.
| Route of Administration | Mechanism of Failure / Clinical Challenge | Physiological Cause |
| Oral (PO) Medications(Short- & Long-Acting) | Failed to achieve therapeutic plasma concentrations or predictable pain relief; erratic onset and peak dynamics. | Severe autonomic diabetic neuropathy and gastroparesis, causing delayed, inconsistent gastric emptying and altered enteric drug absorption. |
| Intravenous (IV) Access | Rapidly became unviable for sustained, frequent administration; high rate of line failure. | Severe depletion of peripheral veins secondary to recurrent acute hospitalizations and frequent vascular access attempts. |
| Subcutaneous (SQ) Regimen | Discontinued upon admission; failure of the hospital team to re-establish the baseline outpatient delivery model. | Interruption of outpatient provider continuity combined with institutional barriers in sourcing specialized compounded hydromorphone (e.g., via suppliers such as Anazao Health). |

Proposed Outpatient Clinician Stabilization Protocol & Multi-Phase Pathway
To overcome these delivery barriers, Dr. Mark Ibsen outlined a multi-phase stabilization strategy designed to bridge the patient from ICU resuscitation to safe outpatient discharge.
Acute Phase 1: ICU PCA Stabilization Parameters
- Modality: Patient-Controlled Analgesia (PCA) pump utilizing hydromorphone.
- Basal Rate: Continuous infusion of at least 2 mg/hour to satisfy baseline physiological tolerance and prevent recurrent withdrawal-induced metabolic instability.
- Demand/Bolus Dose: 0.5 to 1 mg hydromorphone for breakthrough pain.
- Lockout Interval: 20 minutes between demand doses.
- Safety Monitoring Protocols: Continuous monitoring within the ICU setting, including continuous pulse oximetry, blood pressure, heart rate, and optional apnea monitoring. This intensive setting mitigates diversion risks and ensures safety during aggressive dose titration. Dr. Ibsen noted that preemptive, adequate dosing reduces total hydromorphone requirements by eliminating panic-driven redosing and severe pain spikes.

Operational Step-Down Strategy (Phases 2 through 4)
- Phase 2: Compounded Sourcing: While the patient is stabilized on the ICU PCA, hospital pharmacy orders specialized compounded hydromorphone through an accredited compounding facility (such as Anazao Health) to replicate the effective outpatient subcutaneous delivery model.
- Phase 3: Floor Step-Down & Observation: The patient is stepped down to the general medical floor on the compounded subcutaneous regimen (administered by nursing staff or self-administered under supervision) and observed for several days to confirm pharmacokinetic stability and functional recovery.
- Phase 4: Discharge Planning & Outpatient Hand-Off: Prior to discharge, the inpatient team secures an outpatient injectable hydromorphone prescription and establishes a formal hand-off with a qualified outpatient prescriber to maintain continuity of care.

Hospitalist Pitfall: Misattribution of Pharmacokinetic Failure
On November 1, an inpatient hospitalist filed a formal regulatory complaint against Dr. Ibsen, claiming the outpatient physician had intentionally “cut off” the patient and abandoned his care. This misattribution highlights two critical errors in inpatient clinical reasoning:
- Administrative Blindspots: The inpatient provider failed to verify the true cause of treatment disruption—a sudden summary suspension of Dr. Ibsen’s Montana medical license on October 14—mistaking a regulatory stoppage for deliberate physician abandonment.
- Pharmacokinetic Misinterpretation: Inpatient providers frequently attribute high opioid requirements or poor oral response to drug-seeking behavior or non-compliance, failing to recognize that diabetic gastroparesis renders oral short- and long-acting opioids functionally ineffective.

Organizational and Nursing Constraints
Systemic floor-level constraints further complicated care. Once stepped down from the ICU to general medical floors, floor nurses—managing higher patient-to-nurse ratios—were unable to deliver frequent, tightly timed bolus doses of short-acting opioids.
This delay caused plasma drug levels to drop below therapeutic thresholds, repeatedly re-triggering pain spikes, anxiety, and autonomic instability. Combined with a reluctance by hospitalists to consult the outpatient physician of record, these administrative and communication gaps repeatedly destabilized the patient.
These inpatient delivery failures highlight the need for a conceptual framework that aligns immediate delivery routes with comprehensive chronic pain management.

Conceptual Framework: Aligning Inpatient Reality with Pain Management Best Practices
To evaluate why single-modality inpatient interventions fail in high-complexity cases, clinicians can apply Dr. Kayvan Haddadan’s “Toolbox / Golf Bag” framework. This model frames pain management not as a single intervention, but as a deliberate assembly of targeted tools tailored to specific biological mechanisms.

| Tool / Club Category | Clinical Modality | Target Mechanism / Purpose |
| Versatile Mid-Irons | Medications (Anti-inflammatories, nerve-modulating agents, analgesics, topicals) | Reduce pain intensity quickly to enable early movement and sleep restoration. |
| Specialty Clubs | Interventional Procedures (Epidural injections, nerve blocks, radiofrequency ablation, spinal cord stimulation) | Quiet isolated anatomical pain generators to create a therapeutic window for physical rehabilitation. |
| Reliable Irons & Wedges | Physical & Movement Therapies (PT, graded exercise, aquatic therapy, yoga) | Rebuild physical capacity, correct movement biomechanics, and directly restore functional activities. |
| Putter & Short Game | Behavioral & Self-Management Strategies (Sleep optimization, pacing, stress reduction, cognitive strategies, mindfulness) | Dampen central nervous system pain amplification, mitigate fear-avoidance behaviors, and restore self-efficacy. |
| Utility Tools | Lifestyle & Supportive Measures (Nutrition, weight management, assistive devices, ergonomic modifications) | Address systemic contributors and daily functional strain to yield cumulative long-term gains. |
| The Golf Bag Itself | Clinician-Patient Relationship & Shared Decision-Making | Establishes the foundational relationship of trust, open communication, and mutual respect that holds all clinical modalities together. |


Dr. Haddadan’s Diagnostic Sequencing Methodology
A clinician does not select tools at random. Dr. Haddadan emphasizes a systematic diagnostic sequencing process to select the appropriate clinical “club” for the patient’s current presentation:
- Comprehensive History Review: Detailed audit of prior interventions—cataloging exact dosages, clear evidence of efficacy, documented side effects, and precise reasons for past failures.
- Focused Physical & Neuromuscular Examination: Objective mapping of active nociceptive, neuropathic, and autonomic pain generators rather than relying solely on subjective reports.
- Diagnostic & Imaging Integration: Careful correlation of structural imaging and electrodiagnostic findings with active clinical symptoms to avoid treating incidental radiological findings.
- Evidence-Based Literature Matching: Aligning proposed therapies with established literature for specific disease states (e.g., matching CRPS or diabetic neuropathy to targeted neuro-modulating protocols).
- Mechanism-Based Tool Selection: Matching the intervention directly to the underlying biological mechanism (e.g., selecting subcutaneous nerve-modulating infusions when gastrointestinal absorption is impaired) to achieve concrete functional goals.

Inpatient Metrics vs. Patient-Centered Realities
A fundamental disconnect often exists between hospitalist priorities and patient goals:
[ CLINICIAN FOCUS ] [ PATIENT PRIORITIES ]• Isolated 0–10 Pain Scales • Pain Reduction linked to Function• Rapid Medication Weaning • Restored Mobility & Walking• Minimizing Opioid Exposure • Uninterrupted Sleep Quality• Short-Term Discharge Metrics • Return to Work, Family & Social Life
Clinical survey data underscores this distinction:
- In surveys of patients with chronic pain conditions, 46% to 57% rank meaningful pain reduction as their top priority specifically because it directly enables mobility, work, sleep, and family participation.
- A large European survey of chronic pain patients revealed that 56% of respondents ranked pain intensity reduction first, closely followed by the restoration of social, family, and household activities.
In Dakota White’s case, the “toolbox” model collapsed. Systemic barriers—including retail pharmacy refusals, regulatory license suspensions, gastroparesis impairing oral mid-irons, and depleted peripheral veins invalidating IV access—stripped away therapeutic options. The hospital care team was left attempting to manage a multi-system metabolic and pain crisis with fragmented, uncoordinated floor interventions.
Bridging these conceptual frameworks with inpatient care allows us to derive core pedagogical insights for acute hospital practice.

Pedagogical Synthesis & Core Learning Takeaways
- Co-Morbidities Alter Pharmacokinetics: Clinicians must not assume oral pain medications absorb predictably in medically complex patients. Autonomic co-morbidities such as diabetic gastroparesis disrupt gastric emptying and enteric absorption, rendering standard oral conversion ratios invalid and necessitating specialized delivery routes (e.g., continuous subcutaneous infusions or PCA modalities).
- Iatrogenic Vulnerability in Care Transitions: Sudden administrative, legal, or regulatory interruptions in chronic pain therapy represent major patient safety threats. In insulin-dependent diabetic patients, abrupt opioid withdrawal can precipitate massive counter-regulatory hormone release and severe Diabetic Ketoacidosis (DKA), demonstrating that chronic pain continuity is directly linked to systemic organ survival.
- Function-Oriented Pain Metrics: Therapeutic success must be evaluated by functional capacity, metabolic stability, and life participation rather than isolated 0–10 numeric pain scores. A numeric rating becomes clinically meaningful only when it translates into improved sleep, physiological stabilization, and physical activity.
- Interprofessional Communication & Objectivity: When admitting complex chronic pain patients during acute crises, hospitalists must actively communicate with outpatient providers of record to verify baseline tolerances, historical delivery failures, and the administrative context of treatment interruptions. Inpatient teams must maintain clinical objectivity, avoiding the misattribution of complex physiological crises solely to non-compliance, drug-seeking behavior, or patient fault.

“When managing high-complexity co-morbidities during acute hospital admissions, the primary duty of the physician is to combine objective physiological assessment with clear interprofessional communication—ensuring that acute care transitions preserve stable therapeutic regimens while protecting patient safety and functional autonomy.”

🔓 🔓 🔓
ALL WATCHED OVER BY MACHINES OF LOVING GRACE


BE SURE TO DONATE TO THE MARK IBSEN GOFUNDME DEFENSE FUND, WHERE THE SON ALWAYS RISES!!!
OUR TREE OF KNOWLEDGE SHALL NEVER BE SUPPRESSED


FOR NOW, YOU ARE WITHIN
THE NORMS

REFERENCES:
